Работы, на которые ссылается эта работа

Работ: 61

Работа: COVID-19: well-known drugs, new opportunities

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, Marina
Статья2020Цитирований: 14
ABI
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang +26
Статья2020Цитирований: 12
ABI
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu, Dingyu Zhang, Wenling Wang +15
Статья2020Цитирований: 11
ABI
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
Dawei Wang, Bo Hu, Chang Hu +11
Статья2020Цитирований: 11
ABI
Correspondence - Tranexamic acid for traumatic brain injury
Sasieni, Peter D; id_orcid 0000-0003-1509-8744, Duffy, Stephen W, Cuzick, Jack
Статья2005Цитирований: 11
ABI
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta, Daniel F. McAuley, Michael Brown +3
Статья2020Цитирований: 5
ABI
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang, Ruiyuan Cao, Leike Zhang +7
Другое2020Цитирований: 4
ABI
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
Jérôme R. Lechien, Carlos M. Chiesa‐Estomba, Daniele R. de Siati +30
Статья2020Цитирований: 4
ABI
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen, Qianyun Liu, Deyin Guo
Обзорная статья2020Цитирований: 3
ABI
Coronavirus infections and immune responses
Geng Li, Yaohua Fan, Yanni Lai +9
Обзорная статья2020Цитирований: 3
ABI
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito +2
Обзорная статья2020Цитирований: 3
ABI
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent, Éric Bergeron, Suzanne Benjannet +5
Статья2005Цитирований: 2
ABI
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola +15
Статья2020Цитирований: 2
ABI
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama, Naganori Nao, Kazuya Shirato +15
Статья2020Цитирований: 2
ABI
Vitamin D and the Immune System
Cynthia Aranow
Обзорная статья2011Цитирований: 2
ABI
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger +3
Препринт2020Цитирований: 2
ABI
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
Jared S. Morse, Tyler Lalonde, Shiqing Xu +1
Статья2020Цитирований: 2
ABI
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong, Shasha Hu, Jianjun Gao
Статья2020Цитирований: 2
ABI
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
Miguel Ángel Martı́nez
Обзорная статья2020Цитирований: 2
ABI
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Philippe Colson, Jean‐Marc Rolain, Jean‐Christophe Lagier +2
Другое2020Цитирований: 2
ABI
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yuchen Cao, Qixin Deng, Shixue Dai
Обзорная статья2020Цитирований: 2
ABI
Dapsone and doxycycline could be potential treatment modalities for COVID-19
Ahmed Farouk, Samar Salman
Другое2020Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI